Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Human Immunodeficiency Virus Type 1 (HIV-1) antibody (Biotin)

HIV-1 Reactivity: Human Immunodeficiency Virus (HIV) WB, EIA Host: Goat Polyclonal Biotin
Catalog No. ABIN112752
  • Target
    Human Immunodeficiency Virus Type 1 (HIV-1)
    Reactivity
    Human Immunodeficiency Virus (HIV)
    Host
    • 30
    • 17
    • 2
    Goat
    Clonality
    • 30
    • 16
    Polyclonal
    Conjugate
    • 31
    • 7
    • 5
    • 4
    • 1
    • 1
    Biotin
    Application
    • 34
    • 23
    • 15
    • 13
    • 9
    • 7
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Immunogen
    Purified native p24 from strain IIIB
  • Application Notes
    Avidin and streptavidin amplification systems for ELISA and Western blot.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    4-5 mg/mL (OD280, E0.1% = 1.4)
    Buffer
    0.01 M PBS, pH 7.2, containing 0.09 % sodium azide. No stabilizing proteins have been added
    Preservative
    Sodium azide
    Precaution of Use
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handling Advice
    Avoid repeated freezing and thawing.
    Storage
    4 °C/-20 °C
    Storage Comment
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target
    Human Immunodeficiency Virus Type 1 (HIV-1)
    Alternative Name
    HIV-1
    Target Type
    Virus
    Background
    HIV is a highly variable virus which mutates very readily. This means there are many different strains of HIV, even within the body of a single infected person. The strains of HIV1 can be classified into three groups : the "major" group M, the "outlier" group O and the "new" group N. These three groups may represent three separate introductions of simian immunodeficiency virus into humans. Group O appears to be restricted to West-Central Africa and group N, discovered in 1998 in Cameroon, is extremely rare. More than 90 % of HIV1 infections belong to HIV1 group M.Synonyms: HIV-I, HIV1, Human immunodeficiency virus type 1
You are here:
Support